| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444124 | European Journal of Cancer | 2013 | 10 Pages |
Abstract
Adding aflibercept to gemcitabine did not improve OS in patients with metastatic pancreatic cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Philippe Rougier, Hanno Riess, Robert Manges, Petr Karasek, Yves Humblet, Carlo Barone, Armando Santoro, Sylvie Assadourian, Laurence Hatteville, Philip A. Philip,